Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Fresh wave of Russian attacks on Ukraine kills two in Kyiv
Israelis mark three years since Hamas attack that set off Gaza assault
Houthis launch missiles at Yemen's Aden airport as fighting intensifies
Russia says tanker crew rescued in Black Sea after attack set ship ablaze
Kenya confirms first Ebola case
